Prosecution Insights
Last updated: April 18, 2026
Application No. 18/363,564

AUTO-INJECTION DEVICE

Non-Final OA §102
Filed
Aug 01, 2023
Examiner
CARPENTER, WILLIAM R
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Shl Medical AG
OA Round
2 (Non-Final)
54%
Grant Probability
Moderate
2-3
OA Rounds
3y 7m
To Grant
99%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allow Rate
539 granted / 991 resolved
-15.6% vs TC avg
Strong +53% interview lift
Without
With
+53.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
63 currently pending
Career history
1054
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
48.5%
+8.5% vs TC avg
§102
19.9%
-20.1% vs TC avg
§112
23.8%
-16.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 991 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Drawings The drawings were received on 18 August 2025. These drawings are entered. Specification Amendments to the specification were received on 18 August 2025. These amendments are entered. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (g)(1) during the course of an interference conducted under section 135 or section 291, another inventor involved therein establishes, to the extent permitted in section 104, that before such person’s invention thereof the invention was made by such other inventor and not abandoned, suppressed, or concealed, or (2) before such person’s invention thereof, the invention was made in this country by another inventor who had not abandoned, suppressed, or concealed it. In determining priority of invention under this subsection, there shall be considered not only the respective dates of conception and reduction to practice of the invention, but also the reasonable diligence of one who was first to conceive and last to reduce to practice, from a time prior to conception by the other. Claim(s) 11-26, 28, 31-36 is/are rejected under pre-AIA 35 U.S.C. 102(g) as failing to demonstrate due diligence as to provoking interference over U.S. Publication No. 2022/0054757 (“Houmand”) based on the publication thereof on 24 February 2022 which antedates the first appearance of the instant claims (01 August 2023) by more than one year. 35 U.S.C. 135(a)(2) recites: “(2) TIME FOR FILING.—A petition under this section with respect to an invention that is the same or substantially the same invention as a claim contained in a patent issued on an earlier application, or contained in an earlier application when published or deemed published under section 122(b), may not be filed unless such petition is filed during the 1-year period following the date on which the patent containing such claim was granted or the earlier application containing such claim was published, whichever is earlier. Specifically, while the instant claims are purported to be copied from U.S. Patent No. 11,400,222 (published on 02 August 2022), the instant claims first appeared in publication in the above noted pre-grant publication in identical form to those which later issued. Interference Applicant has suggested an interference pursuant to 37 CFR 41.202(a) in a communication filed 01 August 2023. Applicant failed to (1) identify all claims the applicant believes interfere, and/or (2) propose one or more counts, and/or (3) show how the claims correspond to one or more counts. See 37 CFR 41.202(a)(2) and MPEP § 2304.02(b). Applicant failed to provide a claim chart comparing at least one claim of each party corresponding to the count. See 37 CFR 41.202(a)(3) and MPEP § 2304.02(c). Applicant failed to provide a detailed explanation as to why applicant will prevail on priority. See 37 CFR 41.202(a)(4), (a)(6), (d) and MPEP § 2304.02(c). Applicant failed to provide a claim chart showing the written description for each claim in the applicant’s specification. See 37 CFR 41.202(a)(5) and MPEP § 2304.02(d). Furthermore, as noted above, the instant claims have been rejected under 35 USC 102(g) inasmuch as any petition to consider prior conception and invention for purposes of interferences was not made within at least one year as per the earliest publication of the claims in question. As such, there is insufficient showing that Applicant possesses the necessary standing to bring forth a claim of interference and would be likely to prevail. Response to Arguments Applicant’s arguments with respect to the noted issues under 35 USC 112(a) and (b) been fully considered and are persuasive. As such, these rejections have been withdrawn. However, as noted above there presents new issues concerning the timeliness as to the filing of the instant claims for purposes of initiating interference proceedings. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to WILLIAM R CARPENTER whose telephone number is (571)270-3637. The examiner can normally be reached Mon. to Thus. - 7:00AM to 5:00PM (EST/EDT). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, KEVIN SIRMONS can be reached at (571) 272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WILLIAM R CARPENTER/Primary Examiner, Art Unit 3783 10/01/2025
Read full office action

Prosecution Timeline

Aug 01, 2023
Application Filed
Aug 01, 2023
Response after Non-Final Action
Feb 13, 2025
Non-Final Rejection — §102
Aug 12, 2025
Applicant Interview (Telephonic)
Aug 12, 2025
Examiner Interview Summary
Aug 18, 2025
Response Filed
Aug 18, 2025
Response after Non-Final Action
Oct 01, 2025
Non-Final Rejection — §102
Feb 03, 2026
Applicant Interview (Telephonic)
Feb 03, 2026
Examiner Interview Summary
Mar 31, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599753
INTRAVENOUS CATHETER ASSEMBLY
2y 5m to grant Granted Apr 14, 2026
Patent 12594409
SLEEVE FOR RETENTION OF A SURGICAL PORT COMPRISING FLANGES THAT ARE REVERSIBLY RADIALLY EXPANDABLE
2y 5m to grant Granted Apr 07, 2026
Patent 12576004
MASK
2y 5m to grant Granted Mar 17, 2026
Patent 12576255
ADJUSTABLE SEAL
2y 5m to grant Granted Mar 17, 2026
Patent 12569623
DRUG INJECTION CONTROL DEVICE HAVING STABLE OPERATION STRUCTURE OF INJECTION BUTTON THROUGH BUTTON PLATE POSITIONED IN DOSE DIAL
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

2-3
Expected OA Rounds
54%
Grant Probability
99%
With Interview (+53.3%)
3y 7m
Median Time to Grant
Moderate
PTA Risk
Based on 991 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month